美国 · SEC FORM 4
Embecta Corp.
EMBC · Nasdaq · CIK 0001872789 · Healthcare · Medical Instruments & Supplies
内部人信号
4 位买方 · 4 条买入交易行 · $557.9K 买入总额
为什么有这个信号？
评分构成
每条进度条表示其对当前分数的贡献；权重和公式保持不变。
哪些因素限制了当前分数？
- ⚠ 角色得分低 · 买入者中职位最高的是：President and CEO（CEO、董事长和持股 10% 以上的股东得分最低）
- ⚠ Purchase activity is becoming less recent
- ✓ Cluster breadth is broad · 4+ insiders
Purchase-size comments are relative to the model scale. Average daily volume is a separate market-context diagnostic.
US-v1.2 按当前 180 天规则给合资格的股票买入打分。分数只表示研究的先后，不是收益预测或概率。回测没有显示美国分数越高、之后的表现越好。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
Showing the six most active owners; 1 additional owner(s) remain in Form 4 申报证据.
买方广度与集中度
Roles in the peak window: Director, Pres, Pharm Svc&Prod Mgmt, CLO, President and CEO, SVP and CFO. Concentration uses priced qualifying P lines only and does not change the saved score.
信号历史
最新留档分数
- 68.8
- 68.7
- 68.6
- 68.5
- 68.3
Only scores saved when a full US scoring run completed are shown; gaps are not reconstructed.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
市场背景补充近期价格表现与风险信息，不影响内部人信号。
价格表现
- 1M
- +16.3%
- 3M
- +77.1%
- 6M
- -35.8%
- 12M
- -58.9%
波动率与流动性
- 波动率
- 72.5%
- Beta
- —
- 平均每日成交额
- USD 7.7M
估值
- 市值
- USD 322.1M
- P/E
- 3.4×
基本面
- 利润率
- 8.8%
- ROE
- —
- 细分行业
- Medical Instruments & Supplies
市场数据
价格数据截至：2026-10-11 · 价格来源：OpenBB/yfinance; 成交量来自 本机价格缓存 (yfinance) · 来自 SEC 申报文件：市值, P/E, 利润率 · 财年截止日：2025-09-30 · 市值 = 申报文件封面所列的已发行股数 × 最新收盘价。股数日期：2026-07-31 · Status: PASS
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 5,825,802
- 上期报告
- 5,547,979
- 日均成交量
- 1,073,095
- 回补天数
- 5.4
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-08-12 | Mann Jeffrey Z | 买入 (P) | Common Stock | 20,000 | USD 4.99 | USD 99,800 | SEC 申报 ↗ |
| 2026-08-12 | Kurdikar Devdatt | 买入 (P) | Common Stock | 30,000 | USD 4.70 | USD 141,000 | SEC 申报 ↗ |
| 2026-08-12 | HOMBACH ROBERT J. | 买入 (P) | Common Stock | 45,000 | USD 4.97 | USD 223,650 | SEC 申报 ↗ |
| 2026-08-12 | Elguicze Jacob | 买入 (P) | Common Stock | 20,000 | USD 4.67 | USD 93,400 | SEC 申报 ↗ |
| 2025-05-23 | Melcher David F | 买入 (P) | Common Stock | 10,000 | USD 10.60 | USD 106,000 | SEC 申报 ↗ |
| 2025-02-25 | Melcher David F | 买入 (P) | Common Stock | 13,000 | USD 13.67 | USD 177,710 | SEC 申报 ↗ |
| 2024-02-12 | Melcher David F | 买入 (P) | Common Stock | 2,000 | USD 16.25 | USD 32,500 | SEC 申报 ↗ |
| 2023-09-08 | Melcher David F | 买入 (P) | Common Stock | 6,233 | USD 15.77 | USD 98,294 | SEC 申报 ↗ |
| 2023-08-10 | Mann Jeffrey Z | 买入 (P) | Common Stock | 4,700 | USD 21.67 | USD 101,849 | SEC 申报 ↗ |
| 2023-08-10 | Kurdikar Devdatt | 买入 (P) | Common Stock | 5,000 | USD 21.81 | USD 109,050 | SEC 申报 ↗ |
| 2023-08-10 | Elguicze Jacob | 买入 (P) | Common Stock | 4,625 | USD 21.66 | USD 100,178 | SEC 申报 ↗ |
| 2023-02-15 | Melcher David F | 买入 (P) | Common Stock | 3,100 | USD 32.93 | USD 102,083 | SEC 申报 ↗ |
| 2023-02-15 | Melcher David F | 买入 (P) | Common Stock | 3,100 | USD 32.51 | USD 100,781 | SEC 申报 ↗ |
Form 4 申报证据
29 transaction lines in the latest 365-day window; 136 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-04 | Morris Milton Mayo | 卖出 (S) | Common Stock | 6,293 | USD 5.88 | USD 37,003 | SEC 申报 ↗ |
| 2026-08-12 | Mann Jeffrey Z | 买入 (P) | Common Stock | 20,000 | USD 4.99 | USD 99,800 | SEC 申报 ↗ |
| 2026-08-12 | Kurdikar Devdatt | 买入 (P) | Common Stock | 30,000 | USD 4.70 | USD 141,000 | SEC 申报 ↗ |
展开近期 Form 4 证据 (25 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-04 | Morris Milton Mayo | 卖出 (S) | Common Stock | 6,293 | USD 5.88 | USD 37,003 | SEC 申报 ↗ |
| 2026-08-12 | Mann Jeffrey Z | 买入 (P) | Common Stock | 20,000 | USD 4.99 | USD 99,800 | SEC 申报 ↗ |
| 2026-08-12 | Kurdikar Devdatt | 买入 (P) | Common Stock | 30,000 | USD 4.70 | USD 141,000 | SEC 申报 ↗ |
| 2026-08-12 | HOMBACH ROBERT J. | 买入 (P) | Common Stock | 45,000 | USD 4.97 | USD 223,650 | SEC 申报 ↗ |
| 2026-08-12 | Elguicze Jacob | 买入 (P) | Common Stock | 20,000 | USD 4.67 | USD 93,400 | SEC 申报 ↗ |
| 2026-08-09 | Casner Jean | 代扣税 (F) | Common Stock | 1,480 | USD 4.42 | USD 6,542 | SEC 申报 ↗ |
| 2026-06-01 | Roth Anthony M. | 奖励／授予 (A) | Common Stock | 30,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-11 | Reidy Christopher R | 奖励／授予 (A) | Common Stock | 22,841 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-11 | Prange Karen | 奖励／授予 (A) | Common Stock | 22,841 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-11 | Pomeroy Claire | 奖励／授予 (A) | Common Stock | 22,841 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-11 | Morris Milton Mayo | 奖励／授予 (A) | Common Stock | 22,841 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-11 | HOMBACH ROBERT J. | 奖励／授予 (A) | Common Stock | 22,841 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-11 | Anderson Carrie L | 奖励／授予 (A) | Common Stock | 22,841 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2025-11-26 | Roth Anthony M. | 代扣税 (F) | Common Stock | 1,881 | USD 12.57 | USD 23,644 | SEC 申报 ↗ |
| 2025-11-26 | Roth Anthony M. | 奖励／授予 (A) | Common Stock | 32,817 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2025-11-26 | Mann Jeffrey Z | 代扣税 (F) | Common Stock | 19,605 | USD 12.57 | USD 246,435 | SEC 申报 ↗ |
| 2025-11-26 | Mann Jeffrey Z | 奖励／授予 (A) | Common Stock | 104,050 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2025-11-26 | Kurdikar Devdatt | 代扣税 (F) | Common Stock | 128,630 | USD 12.57 | USD 1,616,879 | SEC 申报 ↗ |
| 2025-11-26 | Kurdikar Devdatt | 奖励／授予 (A) | Common Stock | 392,012 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2025-11-26 | Elguicze Jacob | 代扣税 (F) | Common Stock | 24,782 | USD 12.57 | USD 311,510 | SEC 申报 ↗ |
| 2025-11-26 | Elguicze Jacob | 奖励／授予 (A) | Common Stock | 125,613 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2025-11-26 | Curtis Shaun | 代扣税 (F) | Common Stock | 15,380 | USD 12.57 | USD 193,327 | SEC 申报 ↗ |
| 2025-11-26 | Curtis Shaun | 奖励／授予 (A) | Common Stock | 49,094 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2025-11-26 | Casner Jean | 代扣税 (F) | Common Stock | 3,325 | USD 12.57 | USD 41,795 | SEC 申报 ↗ |
| 2025-11-26 | Casner Jean | 奖励／授予 (A) | Common Stock | 38,783 | USD 0.00 | USD 0 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | EMBC |
| CIK | 0001872789 |
| 行业 | Healthcare |
| 细分行业 | Medical Instruments & Supplies Yahoo Finance |
| SEC SIC | 3841 Surgical & Medical Instruments & Apparatus |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 136 transaction lines from 2022-04-01 to 2026-09-04 13 P purchase lines · 2 S sale lines · 121 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.